News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer/Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement
|Videos|October 23, 2020

Outside of Treatment in Metastatic Breast Cancer

Author(s)Kristie L. Kahl
Advertisement

Episodes in this series

Kristie L. Kahl and Jamil Rivers
EP. 1 Treatment for Metastatic Breast Cancer
Kristie L. Kahl and Jamil Rivers
EP. 2 Joining a Clinical Trial
EP. 3 Addressing Disparities in Metastatic Breast Cancer
EP. 3 Addressing Disparities in Metastatic Breast Cancer
Kristie L. Kahl and Kate Watson
Now Playing
EP. 4 Outside of Treatment in Metastatic Breast Cancer
EP. 5 Talking with Your Family About Metastatic Breast Cancer
EP. 5 Talking with Your Family About Metastatic Breast Cancer

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Advertisement

Related Content

Advertisement
Inluriyo, an oral therapy for ER+, HER2– metastatic breast cancer with ESR1 mutations, offers a new treatment option after prior endocrine therapy.

FDA Approves Inluriyo for ER+, HER2– Metastatic Breast Cancer

BySpencer Feldman
September 25th 2025
Image of women with pink cap.

A Patient Guide to Understanding HER2-Positive Breast Cancer

BySpencer Feldman
September 19th 2025
Martha Carlson received a diagnosis of metastatic breast cancer in 2015. Read all of Martha's blogs here!

Building Supportive Communities for Patients Navigating Cancer

ByMartha Carlson
August 14th 2025
The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date: © stock.adobe.com.

FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer

BySpencer Feldman
August 12th 2025

Understanding Treatment Options for ER+/HER2–, ESR1-Mutant Metastatic Breast Cancer

ByIgor Makhlin, MD
July 24th 2025
Advertisement
Advertisement

Trending on CURE

1

FDA Grants Breakthrough Therapy Designation to Ficerafusp Alfa in Head and Neck Cancer

2

What Subcutaneous Keytruda Means for Patients With Melanoma

3

Breast Cancer Awareness Month Isn’t Always “Pink and Pretty”

4

The Gifts I Never Asked For: What Cancer Taught Me About What Really Matters

5

What the FDA Approval of Inluriyo Means for Patients With Breast Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.